Surgical Site Infection

Surgical management of hip and knee periprosthetic fractures was associated with high rates of wound complications after total hip and knee arthroplasties, according to published results.

Obesity, depression, morbid weight loss and iron deficiency anemia may be risk factors for surgical site and periprosthetic joint infections in patients undergoing total hip arthroplasty for acetabular fractures, according to results.

Published results showed no statistically significant differences in the rate of surgical site infections after foot and ankle trauma surgery with use of 1g or 2g of cefazolin.

Implementation of an infection reduction bundle may reduce the overall surgical site infection rate among pediatric patients undergoing spinal fusion, according to results.

Use of surgical jackets and bouffants during surgery may be neither beneficial nor cost-effective in preventing surgical site infections, according to published results.

Gathering information on manual surveillance and clinical practices related to surgical site infections, or SSIs, can lead to the development of algorithms for semiautomated surveillance of these infections, according to findings from a retrospective cohort study.

Patients had a low incidence of 30-day unplanned admission after hip arthroscopy, with chronic corticosteroid use, perioperative transfusions and greater BMI identified as independent risk factors, according to published results.

ORLANDO — Treatment with cefazolin may be safe in patients who report a penicillin allergy, may reduce the rate of infection and provide cost-savings in patients undergoing total joint replacement, according to a presenter at the Current Concepts in Joint Replacement Winter Meeting.

NEW ORLEANS — Results presented at the AAP National Conference & Exhibition showed use of intrawound vancomycin powder and betadine irrigation at the end of posterior spinal fusion significantly lowered the surgical site infection rate in patients with idiopathic scoliosis.

Phase 3 trial results indicated the oral antibiotic known as RHB-104 led to durable clinical remission in patients with Crohn’s disease, and a recent study showed that fecal microbiota transplantation lowered mortality in patients with severe and fulminant Clostridioides difficile infection